Simplex Trading’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,577
Closed -$15.7M 8504
2019
Q3
$15.7M Sell
1,577
-35
-2% -$3.33K 0.04% 290
2019
Q2
$14.9M Sell
1,612
-5,459
-77% -$518K 0.04% 281
2019
Q1
$66.7M Buy
7,071
+2,642
+60% +$231K 0.19% 66
2018
Q4
$28.4M Buy
4,429
+1,232
+39% +$90.9K 0.08% 151
2018
Q3
$28.6M Sell
3,197
-3,848
-55% -$340K 0.09% 152
2018
Q2
$56M Buy
7,045
+1,886
+37% +$157K 0.22% 60
2018
Q1
$6.02M Buy
5,159
+477
+10% +$45.8K 0.26% 70
2017
Q4
$3.51M Buy
4,682
+2,326
+99% +$262K 0.15% 114
2017
Q3
$228K Sell
2,356
-1,903
-45% -$259K 0.01% 1104
2017
Q2
$1.09M Buy
4,259
+2,302
+118% +$282K 0.05% 337
2017
Q1
$645K Buy
1,957
+621
+46% +$74.3K 0.03% 548
2016
Q4
$406K Sell
1,336
-2,417
-64% -$269K 0.02% 642
2016
Q3
$863K Buy
3,753
+103
+3% +$11.1K 0.06% 304
2016
Q2
$1.25M Buy
3,650
+2,179
+148% +$225K 0.08% 222
2016
Q1
$849K Sell
1,471
-1,580
-52% -$163K 0.07% 264
2015
Q4
$512K Buy
3,051
+752
+33% +$87K 0.04% 422
2015
Q3
$1.39M Buy
2,299
+212
+10% +$26.3K 0.1% 181
2015
Q2
$337K Sell
2,087
-212
-9% -$24.2K 0.03% 526
2015
Q1
$848K Buy
2,299
+946
+70% +$113K 0.1% 196
2014
Q4
$268K Buy
+1,353
New +$143K 0.03% 474

Other funds holding CELG

Simplex Trading's CELG Position: Q4 2019 in Review

Simplex Trading sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 24,695 shares — an estimated $2.45M sold.

Simplex Trading first reported a position in CELG in Q4 2014 and held it in 18 quarters. The position peaked at $29.2M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Simplex Trading reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Simplex Trading sold 24,695 Celgene Corp shares in Q4 2019, an estimated $2.45M.
  • Simplex Trading first reported a position in Celgene Corp in Q4 2014 and held it in 18 quarters.
  • Simplex Trading's Celgene Corp position peaked at $29.2M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.